Synthesis of novel cyclopropylic sulfones and sulfonamides acting as glucokinase activators

Tetrahedron Letters

Volumn 47, Issue 16, 2006, Pages 2675-2678

  Heuser, Stefan ^a   Barrett, David G ^a   Berg, Martina ^a   Bonnier, Benjamin ^b   Kahl, Astrid ^a   De La Puente, Maria Luz ^c   Oram, Niall ^d   Riedl, Rainer ^a   Roettig, Ulrike ^a   Gil, Gema Sanz ^c   Seger, Erich ^a   Steggles, David J ^d   Wanner, Jutta ^a,e   Weichert, Andreas G ^a  

^a LILLY DEUTSCHLAND GMBH   (Germany)

^b Eli Lilly Benelux   (Belgium)

^c ELI LILLY AND COMPANY   (Spain)

^d ELI LILLY AND COMPANY   (United States)

^e ROCHE BIOSCIENCE   (United States)

Author keywords

Cyclopropanes; Glucokinase activators; Halogen sulfur exchange; Sulfonamides; Sulfones

Indexed keywords

CYCLOPROPYLIC SULFONE DERIVATIVE; GLUCOKINASE; SULFONAMIDE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; ENZYME ACTIVATION; SYNTHESIS;

EID: 33644971224     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.02.110     Document Type: Article

References (50)

1. F.M. Matschinsky Diabetes 45 1996 22 241
2. Y. Liang, H. Najafi, R.M. Smith, E.C. Zimmerman, M.A. Magnuson, M. Tal, and F.M. Matschinsky Diabetes 41 1992 792 806
3. T. Ferre, E. Riu, F. Bosch, and A. Valera FASEB J. 10 1996 1213 1218
4. WO 01/44216.
5. J. Grimsby, R. Sarabu, W.L. Corbett, N.-E. Haynes, F.T. Bizzarro, J.W. Coffey, K.R. Guertin, D.W. Hilliard, R.F. Kester, P.E. Mahaney, L. Marcus, L. Qi, C.L. Spence, J. Tengi, M.A. Magnuson, C.A. Chu, M.T. Dvorozniak, F.M. Matschinsky, and J.F. Grippo Science 301 2003 370 373
6. WO 2004/050645 A1.
7. D. McKerrecher, J.V. Allen, S.S. Bowker, S. Boyd, P.W.R. Caulkett, G.S. Currie, C.D. Davies, M.L. Fenwick, H. Gaskin, E. Grange, R.B. Hargreaves, B.R. Hayter, R. James, K.M. Johnson, C. Johnstone, C.D. Jones, S. Lackie, J.W. Rayner, and R.P. Walker Bioorg. Med. Chem. Lett. 15 2005 2103 2106
8. A.L. Castelhano, H. Dong, M.C.T. Fyfe, L.S. Gardner, Y. Kamikozawa, S. Kurabayashi, M. Nawano, R. Ohashi, M.J. Procter, L. Qiu, C.M. Rasamison, K.L. Schofield, V.K. Shah, K. Ueta, G.M. Williams, D. Witter, and K. Yasuda Bioorg. Med. Chem. Lett. 15 2005 1501 1504
9. A.M. Efanov, D.G. Barrett, M.B. Brenner, S.L. Briggs, A. Delaunois, J.D. Durbin, U. Giese, H. Guo, M. Radloff, G.S. Gil, S. Sewing, Y. Wang, A. Weichert, A. Zaliani, and J. Gromada Endocrinology 146 2005 3696 3701
10. SAR results will be published and discussed elsewhere in due course.
11. J.A. Murphy, K.A. Scott, R.S. Sinclair, C. Gonzalez Martin, A.R. Kennedy, and N. Lewis J. Chem. Soc., Perkin Trans. 1 2000 2395 2408
12. T. Ishiyama, M. Murata, and N. Miyaura J. Org. Chem. 60 1995 7508 7510
13. H.E. Simmons, and R.D. Smith J. Am. Chem. Soc. 80 1958 5323 5324
14. H.E. Simmons, and R.D. Smith J. Am. Chem. Soc. 81 1959 4256 4265
15. J. Furukawa, N. Kawabata, and J. Nishimura Tetrahedron Lett. 7 1966 3353 3354
16. J. Furukawa, N. Kawabata, and J. Nishimura Tetrahedron 24 1968 53 58
17. A.B. Charette, and H. Juteau J. Am. Chem. Soc. 116 1994 2651 2652
18. A.B. Charette, H. Juteau, H. Lebel, and C. Molinaro J. Am. Chem. Soc. 120 1998 11943 11952
19. A.B. Charette, and J.-F. Marcoux Synlett 1995 1197 1207
20. C.R. Johnson, and C.W. Schroeck J. Am. Chem. Soc. 95 1973 7418 7423
21. see also: Y. Long, Y. Yuan, and Y. Shi J. Am. Chem. Soc. 125 2003 13632 13633 and references cited therein
22. F.D. Bellamy, and K. Ou Tetrahedron Lett. 25 1984 839 842
23. M.P. Doyle, and W.J. Bryker J. Org. Chem. 44 1979 1572 1574
24. R.P. Hanzlik, P.E. Weller, J. Desai, J. Zheng, L.R. Hall, and D.E. Slaughter J. Org. Chem. 55 1990 2736 2742
25. H.F. Wilson, and D.S. Tarbell J. Am. Chem. Soc. 72 1950 5200 5205
26. C. Djerassi, M. Gorman, F.X. Markley, and E.G. Oldenburg J. Am. Chem. Soc. 77 1955 568 571
27. For tried procedures see: K. Hayakawa, K. Ueyama, and K. Kanematsu J. Org. Chem. 50 1985 1963 1969
28. S. Sabelle, J. Hydrio, E. Leclerc, C. Mioskowski, and P.-Y. Renard Tetrahedron Lett. 43 2002 3645 3648
29. A. Postigo, and R.A. Rossi J. Chem. Soc., Perkin Trans. 2 2000 485 490
30. N. Zheng, J.C. McWilliams, F.J. Fleitz, J.D. Armstrong III, and R.P. Volante J. Org. Chem. 63 1998 9606 9607
31. P.G. Ciattini, E. Morera, and G. Ortar Tetrahedron Lett. 36 1995 4133 4136
32. A.M. Rane, E.I. Miranda, and J.A. Soderquist Tetrahedron Lett. 35 1994 3225 3226
33. E.I. Miranda, M.J. Diaz, I. Rosado, and J.A. Soderquist Tetrahedron Lett. 35 1994 3221 3224
34. Y. Huang, K. Mahmood, and N.R. Simpson J. Labelled Compd. Radiopharm. 41 1998 9 17
35. J.C. Arnould, M. Didelot, C. Cadilhac, and M.J. Pasquet Tetrahedron Lett. 37 1996 4523 4524
36. F.Y. Kwong, and S.L. Buchwald Org. Lett. 4 2002 3517 3520
37. Phenanthroline was used instead of the described neocuproine: C.G. Bates, R.K. Gujadhur, and D. Venkataraman Org. Lett. 4 2002 2803 2806
38. L. Testaferri, M. Tingoli, and M. Tiecco Tetrahedron Lett. 21 1980 3099 3100
39. L. Testaferri, M. Tiecco, M. Tingoli, D. Chianelli, and M. Montanucci Synthesis 9 1983 751 755
40. P.M. Murphy, V.A. Phillips, S.A. Jennings, N.C. Garbett, J.B. Chaires, T.C. Jenkins, and R.T. Wheelhouse Chem. Commun. 10 2003 1160 1161
41. for transformations from thioethers to thiols see also: G.C. Crawley, and M.T. Briggs J. Med. Chem. 38 1995 3951 3956
42. M. Evers, and L. Christiaens Tetrahedron Lett. 24 1983 377 380
43. S. Hu, and D.C. Neckers J. Org. Chem. 61 1996 6407 6415
44. 3, reflux, 22 h (xylene) 78% (two steps)).
45. A similar isomerization of the corresponding methylsulfone has been reported by Corbett et al. In that case, the stronger electron-withdrawing effect of the sulfone as compared to the bromide apparently increased the rate of isomerization such that treatment with methanolic aqueous base at rt for 20 h resulted in complete isomerization without competing saponification. Subsequent removal of methanol and brief heating afforded the E-carboxylic acid exclusively. When these conditions were applied to the bromide, a mixture of E/Z carboxylic acids was obtained. See Ref. 3a.
46. HPLC was done using a 80 mm ID dynamic axial compression (DAC) Novasep column separating up to 24 g/h of the racemic cyclopropyl alcohol. Conditions: 1 kg Daicel Chiralpak AD (20 μm), mobile phase: 100% MeCN, starting flow rate 150 ml/min, end run flow rate 320 ml/min, 260 nm.
47. K. Bowden, I.M. Heilbron, E.R.H. Jones, and B.C.I. Weedon J. Chem. Soc. 1946 39
48. K.S. Webb Tetrahedron Lett. 35 1994 3457 3460
49. Y.J. Park, H.H. Shin, and Y.H. Kim Chem. Lett. 1992 1483 1486
50. All experimental procedures were similar to those in cited references and any differences are included in stated exp. details.